Literature DB >> 15671629

Pathogenesis of high altitude pulmonary edema: does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak?

Robert J Kaner1, Ronald G Crystal.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent mediator of capillary leak if it gains access to its receptors on the capillary endothelium. We have observed that there are high levels of VEGF compartmentalized in the alveolar epithelial lining fluid of normal humans at levels 500-fold greater than plasma. The potential for high altitude to result in compromise of alveolar epithelial tight junctions and experimental animal studies in which pulmonary edema is induced when VEGF is overexpressed in the alveolar epithelium, suggest a mechanism. We hypothesize that when the epithelial barrier is compromised at high altitude the normally high level of VEGF in the alveolar epithelial fluid has access to the pulmonary endothelium, where it acutely alters permeability, markedly exacerbating the high permeability pulmonary edema that characterizes high altitude pulmonary edema. If correct, this paradigm opens the possibility of testing available anti-VEGF therapies to treat this potentially fatal disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15671629     DOI: 10.1089/ham.2004.5.399

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  9 in total

1.  Dopamine inhibits pulmonary edema through the VEGF-VEGFR2 axis in a murine model of acute lung injury.

Authors:  Pawan K Vohra; Luke H Hoeppner; Gunisha Sagar; Shamit K Dutta; Sanjay Misra; Rolf D Hubmayr; Debabrata Mukhopadhyay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

Review 2.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

3.  VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema.

Authors:  L B Ware; R J Kaner; R G Crystal; R Schane; N N Trivedi; D McAuley; M A Matthay
Journal:  Eur Respir J       Date:  2005-07       Impact factor: 16.671

4.  Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

5.  Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema.

Authors:  Masaki Watanabe; Julie L Boyer; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

6.  Amiloride-sensitive sodium channels and pulmonary edema.

Authors:  Mike Althaus; Wolfgang G Clauss; Martin Fronius
Journal:  Pulm Med       Date:  2010-12-29

7.  The Role of the Endothelium in HPS Pathogenesis and Potential Therapeutic Approaches.

Authors:  Irina Gavrilovskaya; Elena Gorbunova; Valery Matthys; Nadine Dalrymple; Erich Mackow
Journal:  Adv Virol       Date:  2012-06-28

8.  Rhodiola crenulata Extract Alleviates Hypoxic Pulmonary Edema in Rats.

Authors:  Shih-Yu Lee; Min-Hui Li; Li-Shian Shi; Hsin Chu; Cheng-Wen Ho; Tsu-Chung Chang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-28       Impact factor: 2.629

9.  Elevated VEGF Levels in Pulmonary Edema Fluid and PBMCs from Patients with Acute Hantavirus Pulmonary Syndrome.

Authors:  Irina Gavrilovskaya; Elena Gorbunova; Frederick Koster; Erich Mackow
Journal:  Adv Virol       Date:  2012-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.